Covered recipient · General Payments record
ASHLEY N GREENWALT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,781.52
- Reported across 121 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $332.56 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $170.42 | 9 |
| Exact Sciences Corporation | $68.42 | 3 |
| GlaxoSmithKline, LLC. | $27.16 | 2 |
| Merck Sharp & Dohme Corporation | $20.69 | 1 |
| Seqirus USA Inc | $16.19 | 1 |
| Novo Nordisk AS | $15.81 | 1 |
| PFIZER INC. | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.35 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107251529 | CMS |
| ABBVIE INC. | $28.72 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107251531 | CMS |
| ABBVIE INC. | $17.34 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107251533 | CMS |
| ABBVIE INC. | $17.39 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107251535 | CMS |
| ABBVIE INC. | $17.78 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107251537 | CMS |
| ABBVIE INC. | $17.78 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107251539 | CMS |
| ABBVIE INC. | $17.78 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107251541 | CMS |
| ABBVIE INC. | $19.71 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107251543 | CMS |
| ABBVIE INC. | $9.57 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107251545 | CMS |
| Exact Sciences Corporation | $22.61 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114535164 | CMS |
| Exact Sciences Corporation | $22.24 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114535168 | CMS |
| Exact Sciences Corporation | $23.57 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114535173 | CMS |
| GlaxoSmithKline, LLC. | $13.69 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116478397 | CMS |
| GlaxoSmithKline, LLC. | $13.47 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116594868 | CMS |
| Merck Sharp & Dohme LLC | $20.69 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141801358 | CMS |
| Novo Nordisk Inc | $15.81 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100268382 | CMS |
| PFIZER INC. | $13.87 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131123612 | CMS |
| Seqirus USA Inc | $16.19 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125639150 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.